Reply: Radiopharmaceutical Extravasations CanHave Consequences
Journal of Nuclear Medicine · 2023
DOI: 10.2967/jnumed.123.265920 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Nuclear Medicine, 2023. Verfasst von Ashwin Singh Parihar und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Radiopharmaceuticals, Extravasation of Diagnostic and Therapeutic Materials. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
REPLY: We would like to thank the author for his interest in our work and for this opportunity to address his queries. The author raises several concerns about our large retrospective study. We had described a limitation of our methodology that involved reviewing the clinical reports for reported
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Parihar, A. S., Raymond-Schmidt, L., Crandall, J. P., Dehdashti, F., & Wahl, R. L. (2023). Reply: Radiopharmaceutical Extravasations CanHave Consequences. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.265920
Vancouver
Parihar AS, Raymond-Schmidt L, Crandall JP, Dehdashti F, Wahl RL. Reply: Radiopharmaceutical Extravasations CanHave Consequences. Journal of Nuclear Medicine. 2023. doi:10.2967/jnumed.123.265920
BibTeX
@article{Parihar2023,
author = {Parihar, Ashwin Singh and Raymond-Schmidt, Lisa and Crandall, John P and Dehdashti, Farrokh and Wahl, Richard L},
title = {Reply: Radiopharmaceutical Extravasations CanHave Consequences},
journal = {Journal of Nuclear Medicine},
year = {2023},
doi = {10.2967/jnumed.123.265920}
}
EUVIMED